Cell and Gene Commercialization

  1. How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory Friction 6/30/2025

     Industry leaders share their philosophy on reducing product failure, embracing AI, and building dynamic teams to stay ahead of the curve to bring curative CGT therapies to patients.

  2. Ori Spotlight: How Early Automation Strategies Reduce Costs And Improve Patient Access 6/20/2025

    A pioneer in regenerative medicine reveals how to bridge the gap from research to reality. Learn how early automation and strategic partnerships can slash costs and expand patient access to therapies.

  3. Perspectives And Projections On The 2025 Biotech Landscape 6/13/2025

    Listen to Aditya Kotta discuss key biotech trends, from post-COVID market shifts to global R&D and investment strategies, as well as China’s rising role in pharmaceutical innovation.

  4. Amgen Bets On Agility In The Age Of AI 6/13/2025

    The company is speeding up process optimization with tools like predictive analytics, digital twins, and generative AI copilots.

  5. Crafting Scalable Solutions For Maximum Reach And Success 6/12/2025

    Is your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.

  6. Maximizing Impact: Strategies For Building Robust Patient Support Programs 6/12/2025

    Panelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.

  7. The Power Of Integrated Distribution Strategies 6/12/2025

    Discover the power of integrated distribution for cell and gene therapies. Learn from expert speakers how adaptable partnerships can successfully bring these innovative treatments to more patients.

  8. The Hidden Risk In Cell & Gene Therapy Commercialization 6/5/2025

    Of the root causes of new product launch failure, insufficient relative advantage is by far the most important. Let's take a closer look at lessons we can learn from two key (approved) cell therapies.

  9. A Road Map For Transitioning From A Research-Focused To Commercialization Mindset 6/3/2025

    As the timeline for commercialization closes in, it’s necessary to best position the organization for a successful launch. Where to start?

  10. Accelerating Cell Therapy Development, Manufacturing Workflows 5/30/2025

    Realizing the full potential of modern cell therapies requires optimizing every stage of the process. Explore how advanced solutions can accelerate your development and manufacturing pipeline.